Covered recipient · General Payments record
BRIAN D HAAS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$10,458.65
- Reported across 215 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $341.61 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $72.08 | 3 |
| Dompe US, Inc. | $45.78 | 2 |
| Harrow Eye, LLC | $43.58 | 2 |
| Bausch & Lomb Americas Inc. | $38.45 | 2 |
| Tarsus Pharmaceuticals, Inc. | $35.37 | 1 |
| GLAUKOS CORPORATION | $30.27 | 1 |
| Amgen Inc. | $20.62 | 1 |
| Sight Sciences, Inc. | $19.42 | 1 |
| BIOTISSUE HOLDINGS INC. | $18.04 | 1 |
| RxSight Inc | $18.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $25.10 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110585427 | CMS |
| Alcon Vision LLC | $23.99 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110585425 | CMS |
| Alcon Vision LLC | $22.99 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110585423 | CMS |
| Amgen Inc. | $20.62 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111592174 | CMS |
| Bausch & Lomb Americas Inc. | $15.52 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140313572 | CMS |
| Bausch & Lomb Americas Inc. | $22.93 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140313570 | CMS |
| BIOTISSUE HOLDINGS INC. | $18.04 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148751350 | CMS |
| Dompe US, Inc. | $24.10 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151398822 | CMS |
| Dompe US, Inc. | $21.68 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151398824 | CMS |
| Glaukos Corporation | $30.27 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982302 | CMS |
| Harrow Eye, LLC | $18.93 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145604410 | CMS |
| Harrow Eye, LLC | $24.65 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145604412 | CMS |
| RxSight Inc | $18.00 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144217806 | CMS |
| Sight Sciences, Inc. | $19.42 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151918601 | CMS |
| Tarsus Pharmaceuticals, Inc. | $35.37 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139100979 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.